Wichtiger Schritt im Kampf gegen Überdosierungen: Nasales Naloxon bald rezeptfrei? Der „Sachverständigenausschuss für Verschreibungspflicht“ am Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) hat am 21.01.2025 einstimmig empfohlen, das…

Over-the-Counter Naloxone and Nonprescription Syringe Availability in Community Pharmacies.  Loera LJ, Lines JE, Mayberry SR, Hilzendager SA, Ferguson AP, Hill LG.  JAMA Netw Open. 2025;8(2):e2458095. doi:10…

Association of safer smoking supply distribution with participant encounters and naloxone distribution from syringe services programs: Findings from the National Survey of Syringe Services Programs in the United States.  Chung EO, Patel SV, We…

Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.  Dahan A, Franko TS, Carroll JW, Craig DS, Crow C, Galinkin JL, Garrity JC, Peterson J, Rausch DB.  Front Publi…

Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients. Amaducci A, Aldy K, Campleman SL, Li S, Meyn A, Abston S, Culbreth RE, Krotulski A, Logan B, Wax  P, Brent J, Manini AF; Toxicology Investigators Con…

Development and preclinical testing of a naloxone prodrug depot for extended protection against opioid overdose.  Aldawod H, Patel AD, Emara R, Liang D, Ho JS, Amin TU, Tuhin MTH, Balgoname A, Kiani A, Ajlouny JM, Felmlee MA, Park MS, Jasti BR…